# Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

> **NCT00751114** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 515 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine
- **DRUG:** Sitagliptin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00751114
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 515 (ACTUAL)
- **Last updated:** 2012-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751114, "Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00751114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*